Recombinant Angiopoietin Like Protein 3 (ANGPTL3) Mus musculus (Mouse) Recombinant protein

ANGPT5; ANG-5; Angiopoietin 5; Angiopoietin-related protein 3

Add to Cart Distributors
Overview
Properties
  • Source Prokaryotic expression, Host E.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationSecreted
  • Molecular Mass 33.3kDa, Accurate 34kDa(Analysis of differences refer to the manual)
  • Residues & TagsAsp22~Pro281 with N-terminal His Tag
  • Buffer Formulation20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder, Purity > 97%
  • Isoelectric Point5.8
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Recombinant Angiopoietin Like Protein 3 (ANGPTL3) Packages (Simulation)
  • Recombinant Angiopoietin Like Protein 3 (ANGPTL3) Packages (Simulation)
  • Recombinant Angiopoietin Like Protein 3 (ANGPTL3) Figure. Gene Sequencing (Extract)
  • RPB699Mu02.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Sequence

Usage

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • ATP-binding cassette G5/G8 deficiency causes hypertriglyceridemia by affecting multiple metabolic pathwaysScienceDirect: S1388198111001442
  • Radiomodifying action, Pharmacokinetic and Biodistribution of Ethyl 3, 4, 5-trihydroxybenzoate-Implication in development of radiomitigatorPubmed: 31827168

Recommend products